UAB CCC Clinical Studies Unit — Birmingham, Alabama

UAB CCC Clinical Studies Unit is a clinical research site located in Birmingham, Alabama, United States 35233-2115.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

UAB CCC Clinical Studies Unit has participated in 2 clinical trials.

Therapeutic areas: Non Small Cell Lung Carcinoma, Lymphoma, B-Cell.

Sponsors: Telik, Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UAB CCC Clinical Studies Unit?

UAB CCC Clinical Studies Unit has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UAB CCC Clinical Studies Unit conducted?

UAB CCC Clinical Studies Unit has 2 clinical trials on record. Their work covers Non Small Cell Lung Carcinoma, Lymphoma, B-Cell.

Is UAB CCC Clinical Studies Unit accredited by Crixeo Health?

UAB CCC Clinical Studies Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UAB CCC Clinical Studies Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.